This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The antiviral combination nirmatrelvir-ritonavir (Paxlovid) used for early symptoms of COVID-19 offers limited protection against the development of Long COVID.
A gene editing therapy developed by Vertex Pharmaceuticals and CRISPR Therapeutics can mute sickle cell disease’s most damaging symptoms. Yet treatment may not be as simple as its dramatic benefit makes it seem.
Because of misclassification of diabetes type and the absence of distinction between risk factors, such as birth weight, and diabetes type, uncertainty exists regarding the relationship between obesity and T1D.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
A survey found that the proportion of primary care physicians who were unfamiliar with biologics and their eligibility criteria did not vary based on the number of asthma patients seen each month.
In my decade living in Silicon Valley as a digital health journalist and now an investor, I can’t tell you how many times I’ve heard people in the tech industry claim that doctors don’t have what it takes for a career in entrepreneurship. As the traditional thinking goes, because they’re so risk-averse and lack business training, physicians are not well suited to a high-growth, venture-backed startup environment.
A panel of government advisers finally has endorsed ideas for Congress to solve the particularly thorny problem of surprise ambulance bills , including a cap on how much patients would have to pay if they took an ambulance. Surprise bills have been eliminated for most health care services, but people who take out-of-network ground ambulances remain broadly unprotected — facing potentially thousands of dollars and the threat of collections for a ride that nobody really asks for.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
When Jason Farley was growing up in rural Alabama as a young gay man, he faced a lot of prejudice. “Everything I heard was like I was going to wake up one day and God was going to smite me with AIDS,” he said.
With this approval, fruquintinib is the first and only selective inhibitor of all 3 VEGR receptor kinases to be approved in the United States for previously treated mCRC, regardless of biomarker status.
Apple has for years promised that its devices can help people live healthier, but it has so far produced little concrete evidence of this benefit. Many of the company’s health tools are consumer features without strong ties to the health care system, so there often isn’t a health care outcome to measure as proof. Nevertheless, Apple has embarked on several systematic studies exploring how its devices might be used to more directly improve health conditions, and after several years,
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
NEW YORK — Surgeons have performed the world’s first transplant of an entire human eye, an extraordinary addition to a face transplant — although it’s far too soon to know if the man will ever see through his new left eye. An accident with high-voltage power lines had destroyed most of Aaron James’ face and one eye.
Socioeconomic, racial, and insurance disparities impact individuals' health before and after receiving surgery to treat adolescent idiopathic scoliosis.
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
What’s a radiopharmaceutical? What does it mean to be Zepbound? And who’s to blame for a biotech blow-up? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. As so-called radiopharmaceuticals make headlines in oncology, we explore their fascinating scientific backstory and the biotech gold rush to make them.
The U.S. Food and Drug Administration (FDA) just approved Zepbound (tirzepatide) for chronic weight management. The injectable medication is a new version of Eli Lilly’s Mounjaro, which is approved by the FDA to control blood sugar in people with Type 2 diabetes. Studies show tirzepatide works as an effective drug for people with obesity or those who are overweight and have other health conditions.
Optum Rx is shifting eight different insulin products to its preferred formulary in a bid to address affordability, the company said Thursday. | Optum Rx is shifting eight different insulin products to its preferred formulary in a bid to address affordability, the company said Thursday.
Financial struggles at Bright Health Group and Friday Health Plans have raised concerns about how well the Affordable Care Act's (ACA's) risk adjustment program is working, especially whether it's | Financial struggles at Bright Health Group and Friday Health Plans have raised concerns about how well the Affordable Care Act's risk adjustment program is working, especially whether it's unfairly harming smaller insurers.
Sandoz and Teva have become the first organisations to qualify for the new global Minimized Risk of Antimicrobial Resistance (AMR) certification. This programme was developed by the British Standards Institute (BSI) to verify companies that are taking the necessary steps in ensuring responsible antibiotic manufacturing in the global supply chain, helping to lower the spread of AMR.
As pharmacy workers begin efforts to unionize, Walgreens Boots Alliance Executive Vice President and President of U.S. | Amid labor unrest and slipping financial performance, Walgreens executive John Driscoll said the company will be investing in salary and benefits improvements for its pharmacy workers.
If you’ve ever had a sinus infection, you know how painful it can be. Symptoms like a stuffy nose, pressure or pain behind the eyes, headaches, a cough, and a sore throat, can have you looking for quick relief. The good news is there are a few ways to ease your symptoms. Sinus infections, or sinusitis, occur when the sinuses become infected with a virus or bacteria, making it difficult for mucus to drain.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content